MELBOURNE,Australia,Dec. 25,2024-- Recently,ebm-papst Australia & New Zealand (A&NZ) announced the achievement of operational carbon neutrality for its Australian business operations,covering
ZHONGSHAN,China,Dec. 26,2024-- SUNLU,a leader in the 3D printing industry and a pioneer in filament drying innovations,is proud to unveilits latest development—the FilaDryer E2,an optimum solution fo
PETALING JAYA,Malaysia,Dec. 27,2024-- VISTA Eye Specialist (VISTA),Malaysia\'s leading eye care provider,proudly announces a major milestone in the treatment of dry eye disease. A groundbreaking study
Revolutionary Transparent Antenna with Ultra-Thin Copper Circuit Technology
SEOUL,South Korea,Dec. 23,2024-- CITCo. Ltd.,a leading startup in advanced materials,has been awarded the CES 2025 Innovatio
Celebrating Helsinki Day with a dinner under the sky. Photo:Svante Gullichsen,Helsinki Partners
HELSINKI,Dec. 29,2024-- Next year,Helsinki promises a remarkable cultural program celebrating Finnish de
BEIJING,Dec. 30,2024-- A report from People\'s Daily: According to the Chinese Confucian classic The Book of Rites,"All living things should flourish without harming each other; all ways of life
XIAMEN,China,Dec. 30,2024--Lichen China Limited (Nasdaq: LICN)("Lichen China" or the "Company"),a dedicated financial and taxation service provider inChina today announced that it
On the first Wednesday of every month since 2005, rain or shine, a determined circle forms outside Osaka Station. Holding portraits of silver-haired women and signs reading "Let us build a society together where peace and human rights prevail, preserving the memory of history," members of a Japanese civil group raise voices that Tokyo has long tried to silence.
On the early morning of May 12, a 5.5-magnitude earthquake struck Lhaze county, Xigaze, Southwest China's Xizang Autonomous Region. The earthquake had a focal depth of 10 kilometers and affected surrounding areas, including Saga county.
Taipei-based biotech company Jyong Biotech Ltd. has leveraged a successful IPO to accelerate the development of MCS-2, a promising treatment for benign prostatic hyperplasia (BPH).
